Q1: What is the biological relevance of the XIAP BIR3 domain in cancer research?

A1: The BIR3 domain of XIAP is a critical regulator of apoptosis, as it specifically binds to and inhibits caspase-9, a key initiator of the intrinsic cell death pathway. Overexpression of XIAP is a major mechanism of chemoresistance in many solid tumors, making the BIR3 domain a high-value therapeutic target for SMAC mimetics and small molecule inhibitors aimed at restoring apoptotic sensitivity.

Q2: How does your Fluorescence Polarization assay mechanistically measure binding affinity?

A2: Our assay is based on the principle of molecular rotation. A small fluorescent tracer rotates rapidly in solution, emitting low polarization. When bound to the larger XIAP BIR3 protein, its rotation slows significantly, resulting in a high polarization value. When you introduce an inhibitor, it competes for the binding pocket, displacing the tracer and causing a measurable decrease in polarization signal proportional to its affinity.

In Vitro XIAP Fluorescence Polarization Assay Service

Background Service What We Can Offer Workflow Highlights FAQs Contact

Developing effective inhibitors against the X-linked Inhibitor of Apoptosis Protein (XIAP) is often hampered by challenges such as high background interference in primary screens, inconsistent assay reproducibility, and difficulty in accurately quantifying the binding affinity of high-potency peptidomimetics. To address these hurdles, we offer specialized in vitro XIAP Fluorescence Polarization (FP) Assays designed for the precise identification and validation of next-generation antagonists. Our service leverages advanced rotational diffusion mechanics and optimized tracer technology to deliver a robust, homogeneous, and sensitive readout of compound binding. This approach ensures high-quality, reproducible data with minimal interference, enabling confident hit selection and streamlined progression in your apoptosis-targeting drug discovery pipeline.

Introduction

The X-linked Inhibitor of Apoptosis Protein (XIAP) is a key regulator of programmed cell death, exerting its anti-apoptotic function by binding to and inhibiting effector caspases, particularly caspase-3 and caspase-7. Our in vitro XIAP Fluorescence Polarization (FP) Assay provides a robust biochemical platform for quantifying the interaction between XIAP and its peptide ligands or small molecule inhibitors. By measuring the change in polarization upon tracer binding, this assay enables rapid and accurate assessment of compound affinity and specificity.

Fig.1 XIAP FP-based binding assays. (Creative Biolabs Original) Fig.1 XIAP fluorescence polarization binding assay.

In vitro XIAP Fluorescence Polarization Assays at Creative Biolabs

Creative Biolabs offers a robust biochemical platform for interrogating the Inhibitor of Apoptosis Protein (IAP) family. By specifically targeting the XIAP BIR3 domain, a central regulator of apoptotic resistance, our assay quantifies competitive displacement of a fluorescent tracer from the ligand-binding pocket. This approach delivers precise binding affinities (Ki and IC50), providing the quantitative rigor essential for effective lead optimization campaigns.

What We Can Offer

Tracer Binding Affinity Assay (Kd Determination)

Tracer binding affinity assay at Creative Biolabs. (Creative Biolabs Original)

Compound Competitive Binding Assay (Ki Determination)

Compound competitive binding assay at Creative Biolabs. (Creative Biolabs Original)

Our Service Process

Required Starting Materials: Initiation of the service requires the submission of the candidate compound, provided in solid form or DMSO solution, accompanied by any preferred buffer formulations.

Key Steps:

Workflow of in vitro XIAP fluorescence Polarization assays at Creative Biolabs. (Creative Biolabs Original)

Final Deliverables: Final deliverables include detailed technical summaries featuring assay quality metrics, complete raw data, and graphical representations of IC50 curves.

Key Advantages

Homogeneous Format: No wash steps required, minimizing assay variability and improving throughput.
Real-Time Kinetics: Enables continuous monitoring of binding interactions and compound competition.
Low Sample Consumption: Requires minimal protein and tracer quantities, preserving valuable reagents.
High Sensitivity: Detects weak to strong binders with broad dynamic range.
HTS Compatible: Optimized for 96, 384, and 1536-well plate formats with excellent Z'-factor validation.

FAQ

Q1: What is the biological relevance of the XIAP BIR3 domain in cancer research?
A1: The BIR3 domain of XIAP is a critical regulator of apoptosis, as it specifically binds to and inhibits caspase-9, a key initiator of the intrinsic cell death pathway. Overexpression of XIAP is a major mechanism of chemoresistance in many solid tumors, making the BIR3 domain a high-value therapeutic target for SMAC mimetics and small molecule inhibitors aimed at restoring apoptotic sensitivity.
Q2: How does your Fluorescence Polarization assay mechanistically measure binding affinity?
A2: Our assay is based on the principle of molecular rotation. A small fluorescent tracer rotates rapidly in solution, emitting low polarization. When bound to the larger XIAP BIR3 protein, its rotation slows significantly, resulting in a high polarization value. When you introduce an inhibitor, it competes for the binding pocket, displacing the tracer and causing a measurable decrease in polarization signal proportional to its affinity.

Why Choose Us?

We combine decades of biophysical expertise with HTS-ready capabilities to advance your apoptosis research. Our proprietary tracer technology ensures optimal binding affinity—sensitive enough to detect nanomolar inhibitors while preserving visibility of novel chemotypes. This balance delivers high-quality data for confident lead identification and accelerated drug discovery timelines.

How to contact us?

Unlock the full potential of your drug discovery program. Partner with Creative Biolabs to access industry-leading XIAP FP technology and clinical-grade data. Contact our team today to schedule a technical discussion and request a quote.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: